Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
BIOCON(BIOCON) CRANBURY, N.J. and BENGALURU, India, Sept. 10, 2025 /PRNewswire/ -- Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the inauguration of its first U.S. manufacturing facility in Cranbury, New Jersey, by its wholly owned...
September 10, 2025Manufacturing
Read more →